UPDATE: BTIG Downgrades Neuronetics (STIM) to Neutral on Q3 Revenue Shortfall
Tweet Send to a Friend
(Updated - October 13, 2021 7:20 AM EDT)
BTIG analyst Marie Thibault downgraded Neuronetics (NASDAQ: STIM) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BTIG analyst Marie Thibault downgraded Neuronetics (NASDAQ: STIM) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
